summary
Introduced
10/11/2019
10/11/2019
In Committee
10/14/2019
10/14/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
To amend title XVIII of the Social Security Act to require drug manufacturers to pay a Medicare part B rebate for certain drugs if the price of such drugs increases faster than inflation. This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation.
AI Summary
This bill, the Freedom from Price Gouging Act, amends the Social Security Act to require drug manufacturers to pay a Medicare Part B rebate for certain drugs if the price of those drugs increases faster than inflation. Specifically, the bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation. The bill also outlines the calculation of the rebate amount and includes provisions for enforcement, application to beneficiary coinsurance, and potential expansion of the rebate system to include additional drugs.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (4)
Last Action
Referred to the Subcommittee on Health. (on 10/14/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/116th-congress/house-bill/4663/all-info |
| BillText | https://www.congress.gov/116/bills/hr4663/BILLS-116hr4663ih.pdf |
| Bill | https://www.congress.gov/116/bills/hr4663/BILLS-116hr4663ih.pdf.pdf |
Loading...